🟢 Rezolute Inc is trading 5.4% up today on hyperinsulinism data presentations at ENDO

Rezolute Inc is trading 5.4% up at $4.82, extending its recent multi-day rally following positive clinical developments.

• The company highlighted four new data presentations from its hyperinsulinism program at the Endocrine Society (ENDO) annual meeting on June 17, 2026.
• The move adds to momentum that began after a recent Guggenheim Best Idea call and a price target increase.
• Shares are currently outperforming a broadly mixed market backdrop as the clinical updates reinforce pipeline potential.